United States · Markets & Finance · MarketWatch

Zealand Pharma Shares Drop After Boehringer Obesity Drug Trial Results

Published by MarketWatch · United States 10 h ago

Zealand Pharma shares fell after German partner Boehringer Ingelheim reported results from a late-stage clinical trial of an obesity drug candidate licensed from the Danish…

Read the full article on MarketWatch Sign in to save

MediaNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.marketwatch.com)

Also worth reading

Seeking Alpha

McGraw Hill cuts another $50M of debt, targets 2-2.5x leverage

Quartz

Senate Democrats are questioning the legality of the Pentagon's Venezuela oil deal

OilPrice.com

Zealand Pharma Shares Drop After Boehringer Obesity Drug Trial Results

Share

Also worth reading

McGraw Hill cuts another $50M of debt, targets 2-2.5x leverage

Senate Democrats are questioning the legality of the Pentagon's Venezuela oil deal

Indian Refiners Seek Tankers for Hormuz Oil

Morning Minute: Crypto Gives Up on Congress and Goes After Senators

New York Times Reporting Through a Front Page That Never Published and More

Satlyt, founded by a former Google and SpaceX product manager, raises $8M to run AI on satellites